Filing Details
- Accession Number:
- 0001055726-21-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-29 19:03:13
- Reporting Period:
- 2021-01-27
- Accepted Time:
- 2021-01-29 19:03:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1055726 | Inovio Pharmaceuticals Inc. | INO | Surgical & Medical Instruments & Apparatus (3841) | 330969592 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1771498 | Elizabeth Jacqueline Shea | 660 W. Germantown Pike Plymouth Meeting PA 19462 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-27 | 22,376 | $3.62 | 34,296 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-27 | 22,376 | $12.01 | 11,920 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-27 | 5,960 | $12.04 | 5,960 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-28 | 55,248 | $3.62 | 61,208 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-28 | 16,713 | $12.04 | 44,495 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Option | Disposition | 2021-01-27 | 22,376 | $0.00 | 22,376 | $3.62 |
| Common Stock | Common Stock Option | Disposition | 2021-01-28 | 55,248 | $0.00 | 55,248 | $3.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 177,624 | 2019-03-25 | 2029-03-25 | No | 4 | M | Direct |
| 122,376 | 2019-03-25 | 2029-03-25 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- These transactions were executed in multiple trades at prices ranging from $12.00 to $12.09, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- These transactions were executed in multiple trades at prices ranging from $12.00 to $12.07, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- These transactions were executed in multiple trades at prices ranging from $12.00 to $12.10, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Billionaire Hedge Funds
